Lowering LDL cholesterol benefits older adults, study finds
By
Kristen Fischer
Sep 27, 2023
Lowering low-density lipoprotein, or LDL, cholesterol has similar benefits for older adults and younger people, a study published in the October edition of the Journal of the American College of Cardiology...
First-ever drug can treat ‘bad cholesterol’ that statins miss
By
Kristen Fischer
Aug 29, 2023
A new drug called muvalaplin successfully lowers a genetic form of cholesterol that’s linked to higher risks of strokes and heart attacks, according to a new study published Monday in JAMA. It’s the...
Clinical briefs for Thursday, Aug. 3
By
Kristen Fischer
Aug 03, 2023
Get a grip on grip strength … More adults are getting measles … Low-, moderate-intensity statins associated with drop in cholesterol… Blood pressure meds don’t affect Parkinson’s … Bipolar...
Drop in LDL cholesterol greater with low-, moderate-intensity statins for seniors
Aug 01, 2023
For older versus younger adults, low- to moderate-intensity statins are associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C), according to a study published online Aug. 1...
One in five at-risk patients reject statin therapy, large study finds
By
Alicia Lasek
Feb 28, 2023
More than 20% of patients at high risk for cardiovascular disease refuse to take recommended statin medications, and women are 50% more likely than men to opt out, finds a study involving 24,000 participants.
Clinical briefs for Monday, Nov. 28
By
Alicia Lasek
Nov 28, 2022
FDA receives over 90K foam-breakdown reports tied to Philips Respironics devices … Vitamin D does not ease muscle aches tied to statin use: study … AMDA, AMA urge clinicians to strongly promote vaccination...
Widespread use of statin-aspirin polypill would slash cardiovascular disease, experts contend
By
Alicia Lasek
Oct 14, 2022
The use of inexpensive combination pills could prevent cardiovascular disease on a wide scale, according to a commentary in The Lancet.
Updated U.S. statin guidelines focus on 10-year risk, but evidence lacking for seniors
By
Alicia Lasek
Aug 25, 2022
There is not enough evidence to guide use of statins in adults aged 76 and older for primary CVD prevention. But 10-year risk estimates can be useful for prescribing in younger seniors, the USPSTF says.
Clinical briefs for Thursday, April 7
By
Amy Novotney
Apr 07, 2022
Virtual dementia care program leads to 60% reduction in hospital admissions: study … Biden Administration accelerates effort to prevent, detect and treat Long COVID … BA.2 now behind 72% of all US...
Effect of statins only ‘modest’ in lowering cardiovascular risk, study finds
Mar 16, 2022
Statins are often prescribed as standard-of-care for preventing adverse cardiovascular events in patients with high cholesterol levels. But the results of a new study question the basis for these clinical...